Healthfundr Launches Investment Platform to Democratize Investing in Health and Medtech Innovation

Share Article

Healthfundr is a health-focused funding platform that brings accredited investors the opportunity to invest in compelling early- to growth-stage healthcare companies that are positioned to change the face of health innovation.



“We see these major trends in the market and regulatory environments coming together with significant changes in customer demand to create a need for a platform focused on health innovation."

Healthfundr’s mission is simple: to accelerate healthcare innovation by making it possible for more investors to discover and invest in companies shaping the future of health. The company’s curated web platform gives more accredited investors access to private investments in early- to growth-stage health IT/digital health, diagnostic and medical device companies. Healthfundr increases access to investments that, historically, have been difficult to discover and required minimum investments beyond the reach of most accredited investors.

Healthfundr’s Market Opportunity

Healthfundr has taken advantage of these enormous trends by building a platform that facilitates private investment in health companies. Because of the high risk nature of investing in such companies, Healthfundr only works with accredited investors.

The healthcare industry is undergoing enormous changes to the way it is regulated and the way capital is raised. The most important of these changes include:

  •     The JOBS Act is bringing generational changes to the way capital is raised, including allowing general solicitation, expanding Regulation A, and adopting crowdfunding
  •     The Affordable Care Act is dramatically changing the way we obtain healthcare
  •     Funding for certain types of health companies has been decreasing (biotech/medtech), while growing substantially for other types (health IT/digital health)
  •     Seed funding has exploded across all sectors, while Series A funding has stayed flat and even declined in certain health-related areas
  •     Investors are looking more to technology-enabled, self-service investing in alternative investments, such as private offerings

“We see these major trends in the market and regulatory environments coming together with significant changes in customer demand to create a need for a platform focused on health innovation,” says Healthfundr’s CEO, Jared Iverson.

How Healthfundr Addresses This Market Opportunity

Healthfundr works with investors both directly and through investment funds and financial advisors. For investors seeking self-service investing, the platform allows them to research and learn about companies directly. The platform also gives financial advisers the ability to provide their clients access to this additional asset class.

Healthfundr, along with its investment and medical advisors, carefully screens companies before they are permitted to raise capital through its accredited investor network. Once approved, investors can easily get to know the company by viewing its detailed profile, investment documents and interacting with the management team through the Q&A forum or by scheduling video, telephone, and in-person meetings. Because of Healthfundr’s highly selective approach, potential investors spend less time filtering and more time determining if an investment is right for them.

Healthfundr generally works with companies seeking $500,000 to $5 million in capital, specifically targeting companies that have already raised a round of capital and have obtained customers, regulatory approval, or have other traction indicators. “We’re extremely focused on companies solving specific, tangible problems that our investors can quickly relate to, particularly those that have significant traction and are close to, or have received, any needed regulatory clearance,” says Iverson.

The Healthfundr Team

Healthfundr’s CEO and co-founder, Jared Iverson, is a former securities attorney that has also managed and audited clinical trials for startup and major pharmaceutical companies. The company’s Chief Medical Information Officer and co-founder, Kerry Lowder, is a medical doctor who built one of the largest OB/GYN practices in Idaho and has been the principal investigator in dozens of clinical research studies. Sean Schantzen, Healthfundr’s COO and third co-founder, is a securities attorney who, prior to law school, worked at startup software companies developing and implementing growth strategies, and guiding products. Healthfundr’s lead developer, Scott Stranger, has over twenty years of software and web application development experience, including building applications in the health industry.

NO OFFER OR SOLICITATION: The contents of this piece: (i) do not constitute an offer of securities or a solicitation of an offer to buy securities, and (ii) may not be relied upon in making an investment decision related to any investment offering. Investment offerings and investment decisions may only be made on the basis of an offering circular or confidential private placement memorandum. Investments in early-stage companies are high risk, so investors should only consider such an investment if they do not need any guarantee of income and are able to risk possibly losing their entire investment. No offer or solicitation may be made without a determination that a potential investor is qualified. Securities are offered through ARI Financial Services, Inc., 4745 W, 136th St, Suite 91, Leawood, KS 66224, a broker-dealer registered with FINRA & SIPC. Healthfundr & ARI are not affiliated companies. Prior Performance is not indicative of future results.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jared Iverson
Email >